As of March 2026, Bard has not announced a finalized global settlement for Bard PowerPort claims, despite ongoing litigation affecting thousands of patients. However, legal analysts have outlined potential compensation ranges based on comparable medical device litigation, with settlements expected to fall between $150,000 and $1 million or more depending on injury severity. The litigation is currently in active discovery with 2,828 pending cases in the federal court system, and bellwether trials—test cases used to gauge potential settlement values—are scheduled to begin April 21, 2026. This article covers what patients need to know about the current status of the litigation, expected compensation amounts, upcoming trials, and the timeline for a potential global settlement.
Table of Contents
- What Is Bard PowerPort and Why Are Patients Filing Lawsuits?
- Current Status of the Bard PowerPort MDL Litigation
- Bellwether Trials: The Road Ahead and What They Mean
- Expected Compensation Amounts and Settlement Ranges
- When a Global Settlement Might Be Announced
- Who May Be Eligible to File a Bard PowerPort Claim
- What Happens Next: The Path Forward for Plaintiffs
- Conclusion
What Is Bard PowerPort and Why Are Patients Filing Lawsuits?
The Bard PowerPort is an implanted central venous access device (a port-a-cath) manufactured by C.R. Bard, now part of BD Medical. These ports are surgically implanted beneath the skin and used to deliver medications, chemotherapy, fluids, and nutrients directly into the bloodstream. They’re commonly used by cancer patients, those with chronic illnesses requiring long-term IV therapy, and patients needing repeated blood draws. The device is intended to reduce the need for repeated needle sticks and improve patients’ quality of life during long-term treatments.
Lawsuits have been filed over allegations that Bard PowerPort catheters are prone to fracture, malfunction, and leak. Patients claim the devices failed prematurely, causing serious complications including sepsis, blood infections, cardiac complications, and the need for emergency removal surgery. For example, one patient reported a fractured catheter component that broke off inside their body, requiring surgical removal and leading to a sepsis infection during recovery. The company has faced accusations that it failed to adequately warn patients and healthcare providers about these risks. Multiple studies and FDA safety reports have documented complications associated with the device, prompting the consolidated litigation.
Current Status of the Bard PowerPort MDL Litigation
The Bard PowerPort cases have been consolidated into a multidistrict litigation (MDL) in federal court. As of March 2026, there are 2,828 pending cases in the MDL, reflecting the significant number of patients allegedly harmed by the device. An MDL is a procedural mechanism used when many similar lawsuits are filed against the same defendant, allowing them to be managed together rather than scattered across multiple courts nationwide. This consolidation streamlines discovery, prevents duplicate depositions, and can accelerate settlement negotiations.
The pending cases represent patients from across the United States who claim various injuries related to PowerPort failure. However, it’s important to note that the number of pending cases does not represent the total universe of potentially affected patients. Many patients may not be aware they have a potential claim, and filing deadlines (called statutes of limitations) vary by state. If you believe you’ve been harmed by a Bard PowerPort, acting quickly is important because claim deadlines can limit your right to sue.
Bellwether Trials: The Road Ahead and What They Mean
Bellwether trials are scheduled to begin on April 21, 2026, with the first case going to trial to test the strength of the claims against Bard. Following this initial trial, five additional bellwether trials are scheduled throughout the remainder of 2026 and into early 2027. These test cases are critical in settlement negotiations because their outcomes help both sides understand the likely range of damages a jury might award, which in turn influences settlement discussions. The results of these bellwether trials will significantly impact the overall litigation landscape.
If juries award substantial damages in early cases, Bard will face pressure to settle remaining cases at higher values. Conversely, if early trials result in favorable outcomes for Bard, the company may be less motivated to settle quickly. The first trial outcome on April 21, 2026, will be particularly influential. For example, if a jury awards $500,000 to a plaintiff in the first bellwether case, it sends a strong signal about the potential value of other similar claims, which could accelerate broader settlement discussions.
Expected Compensation Amounts and Settlement Ranges
Legal analysts expect average settlement values for Bard PowerPort claims to fall between $150,000 and $1 million, with cases involving severe injuries potentially exceeding $1 million. These estimates are based on comparable medical device litigation and the severity of injuries reported in cases. The specific amount any individual claimant might receive would depend on several factors: the severity and permanence of their injuries, evidence of Bard’s knowledge of the risks, the strength of medical documentation, the state where they reside, and whether the injury required multiple surgeries or caused long-term disability.
For example, a patient who experienced a catheter fracture but had it removed with minimal complications might reasonably expect settlement compensation on the lower end of the range—potentially $150,000 to $300,000—while a patient who developed life-threatening sepsis, required extended hospitalization, suffered permanent cardiac damage, or required multiple surgeries might expect compensation in the $500,000 to $1 million or higher range. It’s important to understand that these are expected ranges based on litigation analysis, not guarantees. No settlement amount has been announced, and actual settlement values could fall outside these estimates.
When a Global Settlement Might Be Announced
Based on current litigation timelines, legal experts estimate that a global settlement—a comprehensive agreement resolving all or most pending cases—is unlikely to occur before late 2026 or 2027 at the earliest. The bellwether trials scheduled through early 2027 must play out first, as their outcomes will shape settlement negotiations. Bard will likely wait to see the results of multiple trials before committing to a global settlement, and plaintiffs’ attorneys will use trial outcomes as leverage in settlement discussions.
However, settlement discussions could begin earlier than trial outcomes are finalized, particularly if early bellwether trials produce results that encourage settlement. Some cases may also be resolved individually through negotiated settlements before a global agreement is reached. This means some patients could receive compensation before a comprehensive settlement is announced, while others may need to wait for the global resolution. If you have a pending claim, your attorney can advise you on the likelihood and timing of settlement offers in your specific case.
Who May Be Eligible to File a Bard PowerPort Claim
Patients who received a Bard PowerPort implant and experienced a malfunction, fracture, or complication that they believe was caused by device failure may be eligible to file a claim. Eligible injuries typically include catheter fracture, leakage, malfunction, thrombosis (blood clots), sepsis, infection, heart damage from device migration, and other serious complications. However, eligibility varies based on when you received the device, when the injury occurred, and the statute of limitations in your state.
Some patients who experienced complications may have already had their device removed or replaced without fully understanding that the device failure could be the basis for a lawsuit. For instance, if you underwent emergency surgery to remove a fractured PowerPort five years ago and recovered without long-term effects, you may still have a claim depending on your state’s filing deadline and medical evidence. Because each case is unique and deadlines vary, it’s crucial to consult with an attorney experienced in medical device litigation to determine whether you have a viable claim and how much time you have to file.
What Happens Next: The Path Forward for Plaintiffs
The period from now through early 2027 will be critical in the Bard PowerPort litigation. The April 2026 bellwether trial will set the tone for settlement discussions, and subsequent trials will provide additional data points. During this time, the MDL court may also push the parties toward settlement or mediation, and Bard may initiate settlement negotiations based on trial outcomes. For current claimants, this period is when settlement discussions are most likely to intensify.
Prospective claimants should move quickly if they believe they’ve been harmed by a Bard PowerPort, as statutes of limitations could bar claims if they aren’t filed within specific timeframes. New claims can potentially be added to the MDL even as bellwether trials proceed. If you haven’t yet pursued a claim but believe your PowerPort caused you serious harm, consulting with a medical device litigation attorney should be a priority. An attorney can evaluate your case, explain your options, and ensure you meet all applicable deadlines.
Conclusion
While no global Bard PowerPort settlement has been announced as of March 2026, the litigation is moving forward with 2,828 pending cases and bellwether trials scheduled to begin April 21, 2026. Legal analysts expect that a global settlement, if reached, would likely provide compensation ranging from $150,000 to $1 million or more depending on injury severity, though these are estimates based on comparable litigation rather than announced settlement terms. The outcomes of the upcoming bellwether trials will be instrumental in determining both the timeline and value of a potential settlement.
If you or a family member has experienced complications from a Bard PowerPort, now is an important time to seek legal counsel. An attorney experienced in medical device litigation can evaluate your case, explain your options, and help ensure you meet filing deadlines. The evidence you gather—medical records documenting your device failure and resulting injuries—will be crucial in supporting your claim when settlement negotiations occur.